COMMUNIQUÉS West-GlobeNewswire

ADMA Biologics Reports First Quarter 2018 Financial Results
14/05/2018
Key Manufacturing Milestones Achieved During First Quarter RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), today announced its [...]
EDAP TMS SA : EDAP Reports 2018 First Quarter Results
14/05/2018
2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco, May 18-21, 2018 LYON [...]
Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference
14/05/2018
Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14 [...]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference
14/05/2018
BURNABY, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will provide a corporate update and overview of [...]
IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results
14/05/2018
HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology corporation, today released its financial and operational results for the first quarter ended [...]
ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update
14/05/2018
Conference call and webcast scheduled for Tuesday, May 15th at 2:30 pm CET/8:30 am EDT Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in [...]
Molecular Templates, Inc. Reports First Quarter 2018 Financial Results
14/05/2018
MT-3724 Phase Ib Ongoing; Combination Studies Expected to Start in 2H18 AUSTIN, Texas, May 14, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM ) (“Molecular”), a clinical-stage oncology company focused [...]
HealthEquity Sets Date to Announce First Quarter Results Fiscal Year 2019
14/05/2018
Attend Investor Conferences DRAPER, Utah, May 14, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to [...]
Avinger Announces First Quarter 2018 Financial Results
14/05/2018
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first quarter ended [...]
Medigus Broadens Availability of MUSE™ Through Distribution Agreement with MELEKIRMAK in Turkey, Azerbaijan and Georgia
14/05/2018
OMER, Israel, May 14, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]
Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results
14/05/2018
Conference Call Scheduled May 14, 2018 at 4:30 p.m. EDT BERKELEY HEIGHTS, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a [...]
ImmuCell Announces Financial Results for First Quarter of 2018
14/05/2018
PORTLAND, Maine, May 14, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update
14/05/2018
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) RANCHO CORDOVA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care [...]
TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
14/05/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - May 14, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates
14/05/2018
Phase 1 Dose Escalation Trials Progressing for Lead Programs XMT-1522 and XMT-1536 Presented Data of Dolaflexin ® Platform Unique DolaLock Technology and XMT-1522 Synergy with a Checkpoint Inhibitor at AACR 2018 [...]
Acer Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
14/05/2018
Acer continues progression from development to potential commercialization of EDSIVO™ Company appoints Chief Legal Officer and 3 new VPs of Clinical Operations, Program and Alliance Management, and Market Access and [...]
iCAD Reports First Quarter 2018 Financial Results
14/05/2018
Company Expects to Submit PowerLook Tomo Detection Version 2.0 for FDA Approval Shortly Submission to be Based on Promising Results from Pivotal Clinical Reader Study Conference call today at 4:30 p.m. ET NASHUA, N.H., [...]
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights
14/05/2018
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Cara Therapeutics to Present at the International Investigative Dermatology 2018 Meeting
14/05/2018
STAMFORD, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Pages